-
公开(公告)号:US10662184B2
公开(公告)日:2020-05-26
申请号:US16289212
申请日:2019-02-28
Applicant: Xenon Pharmaceuticals Inc.
Inventor: Jean-Christophe Andrez , Kristen Nicole Burford , Sultan Chowdhury , Charles Jay Cohen , Christoph Martin Dehnhardt , Robert Joseph Devita , James Roy Empfield , Thilo Focken , Michael Edward Grimwood , Syed Abid Hasan , James Philip Johnson, Jr. , Alla Yurevna Zenova
IPC: C07D417/12 , C07D417/14 , C07D401/12 , C07D401/14 , C07D451/06 , C07D403/12 , C07D213/76 , C07D237/20 , C07D239/69 , C07D413/12 , C07D261/16 , C07D493/10 , C07D277/52 , C07D285/08
Abstract: This invention is directed to methods of preparing benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.
-
公开(公告)号:US11299490B2
公开(公告)日:2022-04-12
申请号:US16940696
申请日:2020-07-28
Applicant: Xenon Pharmaceuticals Inc.
Inventor: Jean-Christophe Andrez , Kristen Nicole Burford , Sultan Chowdhury , Charles Jay Cohen , Christoph Martin Dehnhardt , Robert Joseph Devita , James Roy Empfield , Thilo Focken , Michael Edward Grimwood , Syed Abid Hasan , James Philip Johnson, Jr. , Alla Yurevna Zenova
IPC: C07D451/06 , C07D403/12 , C07D213/76 , C07D237/20 , C07D239/69 , C07D413/12 , C07D417/12 , C07D261/16 , C07D493/10 , C07D277/52 , C07D285/08 , C07D401/12 , C07D417/14
Abstract: This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.
-
公开(公告)号:US20210171537A1
公开(公告)日:2021-06-10
申请号:US16805895
申请日:2020-03-02
Applicant: Xenon Pharmaceuticals Inc.
Inventor: Jean-Christophe Andrez , David Earl Bogucki , Kristen Nicole Burford , Sultan Chowdhury , Charles Jay Cohen , Shannon Marie Decker , Christoph Martin Dehnhardt , Robert Joseph Devita , James Roy Empfield , Thilo Focken , Michael Edward Grimwood , Syed Abid Hasan , Qi Jia , James Philip Johnson, JR. , Michael Scott Wilson , Alla Yurevna Zenova
IPC: C07D491/107 , C07D493/10 , C07D237/20 , C07D213/76 , C07D239/69 , C07D261/16 , C07D263/50 , C07D275/03 , C07D277/52 , C07D285/08 , C07D401/12 , C07D403/12 , C07D413/12 , C07D417/12 , C07D487/10 , C07D417/14 , C07D451/06
Abstract: This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.
-
公开(公告)号:US20180162868A1
公开(公告)日:2018-06-14
申请号:US15600612
申请日:2017-05-19
Applicant: Xenon Pharmaceuticals Inc.
Inventor: Jean-Christophe Andrez , David Earl Bogucki , Kristen Nicole Burford , Sultan Chowdhury , Charles Jay Cohen , Shannon Marie Decker , Christoph Martin Dehnhardt , Robert Joseph Devita , James Roy Empfield , Thilo Focken , Michael Edward Grimwood , Syed Abid Hasan , Qi Jia , James Philip Johnson, JR. , Michael Scott Wilson , Alla Yurevna Zenova
IPC: C07D491/107 , C07D277/52 , C07D417/12 , C07D213/76 , C07D285/08 , C07D401/12 , C07D403/12 , C07D275/03 , C07D239/69 , C07D261/16 , C07D413/12 , C07D263/50 , C07D487/10
Abstract: This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.
-
公开(公告)号:US11174268B2
公开(公告)日:2021-11-16
申请号:US16805895
申请日:2020-03-02
Applicant: Xenon Pharmaceuticals Inc.
Inventor: Jean-Christophe Andrez , David Earl Bogucki , Kristen Nicole Burford , Sultan Chowdhury , Charles Jay Cohen , Shannon Marie Decker , Christoph Martin Dehnhardt , Robert Joseph Devita , James Roy Empfield , Thilo Focken , Michael Edward Grimwood , Syed Abid Hasan , Qi Jia , James Philip Johnson, Jr. , Michael Scott Wilson , Alla Yurevna Zenova
IPC: C07D491/107 , C07D493/10 , C07D237/20 , C07D213/76 , C07D239/69 , C07D261/16 , C07D263/50 , C07D275/03 , C07D277/52 , C07D285/08 , C07D401/12 , C07D403/12 , C07D413/12 , C07D417/12 , C07D487/10 , C07D417/14 , C07D451/06 , A61K31/395 , A61K31/427
Abstract: This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.
-
公开(公告)号:US10815229B1
公开(公告)日:2020-10-27
申请号:US16821294
申请日:2020-03-17
Applicant: Xenon Pharmaceuticals Inc.
Inventor: Kristen Nicole Burford , Sultan Chowdhury , Christoph Martin Dehnhardt , Thilo Focken , Michael Edward Grimwood , Syed Abid Hasan
IPC: C07D451/06 , C07D403/12 , C07D213/76 , C07D237/20 , C07D239/69 , C07D413/12 , C07D417/14 , C07D261/16 , C07D493/10 , C07D277/52 , C07D285/08 , C07D401/12 , C07D417/12
Abstract: This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.
-
公开(公告)号:US20190194184A1
公开(公告)日:2019-06-27
申请号:US16289212
申请日:2019-02-28
Applicant: Xenon Pharmaceuticals Inc.
Inventor: Jean-Christophe Andrez , Kristen Nicole Burford , Sultan Chowdhury , Charles Jay Cohen , Christoph Martin Dehnhardt , Robert Joseph Devita , James Roy Empfield , Thilo Focken , Michael Edward Grimwood , Syed Abid Hasan , James Philip Johnson, JR. , Alla Yurevna Zenova
IPC: C07D451/06 , C07D285/08 , C07D277/52 , C07D493/10 , C07D261/16 , C07D417/12 , C07D401/12 , C07D239/69 , C07D237/20 , C07D213/76 , C07D403/12 , C07D417/14 , C07D413/12
Abstract: This invention is directed to methods of preparing benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.
-
公开(公告)号:US10246453B2
公开(公告)日:2019-04-02
申请号:US15600490
申请日:2017-05-19
Applicant: Xenon Pharmaceuticals Inc.
Inventor: Jean-Christophe Andrez , Kristen Nicole Burford , Sultan Chowdhury , Charles Jay Cohen , Christoph Martin Dehnhardt , Robert Joseph Devita , James Roy Empfield , Thilo Focken , Michael Edward Grimwood , Syed Abid Hasan , James Philip Johnson, Jr. , Alla Yurevna Zenova
IPC: A61K31/4025 , A61K31/426 , A61K31/427 , A61K31/444 , C07D417/12 , C07D417/14 , C07D401/12 , C07D401/14 , C07D451/06 , C07D403/12 , C07D213/76 , C07D237/20 , C07D239/69 , C07D413/12 , C07D261/16 , C07D493/10 , C07D277/52 , C07D285/08
Abstract: This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.
-
公开(公告)号:US20170334902A1
公开(公告)日:2017-11-23
申请号:US15600490
申请日:2017-05-19
Applicant: Xenon Pharmaceuticals Inc.
Inventor: Jean-Christophe Andrez , Kristen Nicole Burford , Sultan Chowdhury , Charles Jay Cohen , Christoph Martin Dehnhardt , Robert Joseph Devita , James Roy Empfield , Thilo Focken , Michael Edward Grimwood , Syed Abid Hasan , James Philip Johnson, JR. , Alla Yurevna Zenova
IPC: C07D451/06 , C07D401/12 , C07D417/12 , C07D417/14
CPC classification number: C07D451/06 , C07D213/76 , C07D237/20 , C07D239/69 , C07D261/16 , C07D277/52 , C07D285/08 , C07D401/12 , C07D403/12 , C07D413/12 , C07D417/12 , C07D417/14 , C07D493/10
Abstract: This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.
-
-
-
-
-
-
-
-